Abstract View

Author(s): Deepa Gavit*1, Dhara Patel2, Girishna Patel3, Tejas Patel4, Dhananjay Meshram5

Email(s): 1gavitdeepa05@gmail.com

Address:

    Department of Pharmaceutical Quality Assurance, pioneer pharmacy College Nr.Ajwa Crossing sayajipura, vadodara-390019,Gujrat, India

Published In:   Volume - 5,      Issue - 6,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5621  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
The pharmaceutical manufacturing industry is rapidly moving toward digital transformation and advanced quality management systems to improve product quality, manufacturing efficiency, and regulatory compliance. Data-driven quality improvement has become an important approach for identifying process variability, reducing human errors, minimizing deviations, and improving overall manufacturing performance. Modern pharmaceutical industries generate large amounts of production and quality-related data through manufacturing execution systems (MES), laboratory information management systems (LIMS), enterprise resource planning (ERP), process analytical technology (PAT), and automated manufacturing equipment. The proper analysis and utilization of this data help industries in making better decisions, improving process control, and maintaining product consistency. Advanced technologies such as artificial intelligence (AI), machine learning (ML), big data analytics, cloud computing, and Industry 4.0 tools are increasingly being implemented in pharmaceutical manufacturing environments. The regulatory authorities it is including the USFDA, WHO, and ICH emphasize data integrity, quality risk management (QRM) and continuous improvement as essential elements of the modern pharmaceutical quality systems. This review article discusses the concept of data-driven quality improvement in pharmaceutical manufacturing environments, major data sources, digital technologies, statistical tools, regulatory perspectives, benefits, challenges, and future opportunities.

Cite this article:
Deepa Gavit, Dhara Patel, Girishna Patel, Tejas Patel, Dhananjay Meshram. Data-Driven Quality Improvement in Pharmaceutical Manufacturing Environment. IJRPAS, June 2026; 5(6): 277-304DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5621


References not available.

Related Images:



Recent Images



Nanotechnology in Cosmetic Formulations: Recent Advances and Safety Concerns
Analysis of Pro-Inflammatory Cytokines Response Among Typhoid Patients Co-Infection with Plasmodium falciparum In Khartoum State -Sudan
Optimizing OEL and ADE/PDE Compliance in Pharma
Formulation and Evaluation of Quercetin Nanoemulsion Gel for Rheumatoid Arthritis
Formulation and Evaluation of Herbal Oil -Roghan-e-Turb: A Traditional Unani Formulation for Analgesic Activity
Formulation and Evaluation of Anti-Pimple Herbal Serum Enriched with Tulsi, Turmeric, Aloe Vera, Neem
Formulation, Optmization and Evaluation of Curcuma longa and Piper nigrum Hydrogel
A Review on Emerging Technologies in Monitoring and Diagnosing Immune Thrombocytopenia (ITP): Current Trends and Future Directions
Phytochemical Characterisation, In Silico Androgen Receptor Inhibitory Activity, and Fertility-Enhancing Potential of Aqueous–Ethanol Root Extract of Triclisia subcordata Oliv.
Formulation of Effervescent Granules from Bangkal Tree (Nauclea orientalis) Leaf Extract: A Potential  Larvicide Against Aedes Aegypti

Tags